Lindsey Williams

Lindsey Williams has diverse work experience in various roles and industries. Lindsey is the Co-Founder of MyUTI, a digital wellness platform for women with urinary tract infections. At MyUTI, Lindsey focuses on providing on-demand access to testing and clinical experts, while also working towards reducing antibiotic resistance.

Lindsey has also served as the Chief Commercial Officer (CCO) at Otogenetics Corporation, where they were responsible for leading commercial efforts. Prior to that, they founded and served as the President of Corylus Consulting, offering strategic guidance and advisement to companies bringing new products and technology to market. Lindsey leveraged their vast network and market insights to accelerate commercialization and market acceptance.

Lindsey also worked as the Vice President of Business Development at IDbyDNA (acquired by Illumina), contributing to the company's growth and success. Additionally, they served on the Business Advisory Board of RedCrow from 2019 to 2021.

Before embarking on entrepreneurial endeavors, Lindsey gained valuable experience in managerial roles. As the General Manager of Biocraft, Urocraft & Premier Medical Services, they successfully managed financials, implemented strategic sales plans, and achieved significant revenue growth. Lindsey also held the position of Strategic Markets Manager at Decipher Biosciences, Inc. and worked in the Emerging Products division of Myriad Genetics.

Earlier in their career, Lindsey worked as a Strategic Account Executive at Aureon Laboratories and as a Territory Manager in Cardiovascular Specialty Sales at Abbott.

Throughout their career, Lindsey Williams has consistently demonstrated their expertise in strategic planning, commercialization, market analysis, and change management. Their contributions have resulted in revenue growth, increased profitability, and overall success.

Lindsey Williams earned a Bachelor of Science degree in Communication from Kennesaw State University in 2007.